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Abstract 
 
Liver zonation, the spatial separation of different metabolic pathways along the liver 
sinusoids, is fundamental for proper functioning of this organ and its disruption can lead to 
the development of metabolic disorders such as hyperammonemia. Metabolic zonation 
involves the induction of β-catenin signaling around the central veins, but how this patterned 
activity is established and maintained is unclear. Here we show that the signaling molecule 
Rspondin3 is specifically expressed within the endothelial compartment of the central vein. 
Conditional deletion of Rspo3 in mice disrupted activation of central fate demonstrating its 
crucial role in determining and maintaining β-catenin dependent zonation. Moreover, ectopic 
expression of Rspo1, a close family member of Rspo3, induced the expression of pericentral 
markers demonstrating Rspondins to be sufficient to imprint a more central fate. Thus Rspo3 
is a key angiocrine factor that controls metabolic zonation of liver hepatocytes.  
 
  
Introduction 
The liver is a central organ responsible for the metabolism of dietary compounds, regulation 
of blood glucose levels, bile synthesis and biotransformation of xenobiotics and endogenous 
by-products of metabolism. During development, the fetus is able to rely on the metabolic 
activity of the maternal liver. In the neonatal period however, the liver needs to undergo 
several changes until reaching full maturation at weaning (Grijalva and Vakili, 2013). This 
includes specialization of groups of hepatocytes, a process involving the activation of 
specific enzymes that allow effective execution of metabolic tasks. 
The functional unit of the liver consists of the hepatic lobule, which includes a central vein 
connected to four to six portal triads via the hepatic plates. Hepatocytes located within these 
functional units perform specific functions depending on their location within the lobule. 
Three zones of hepatocytes can be distinguished: hepatocytes located closest to the 
periportal triad (zone 1) are exposed to blood with the highest oxygen and nutrient 
concentration and perform the majority of the liver’s metabolic functions including glycogen 
synthesis, gluconeogenesis, protein synthesis and lipid metabolism. The hepatocytes closest 
to the central veins are located in zone 3 and are specialized for biotransformation reactions, 
glycolysis and urea synthesis. Hepatocytes in zone 2 display an intermediate phenotype 
executing both periportal and pericentral functions (Torre et al., 2010).  
On the molecular level, liver zonation is governed by canonical Wnt/β-catenin signaling. Its 
activity is highest around the central vein and nuclear β-catenin directly regulates the 
activation of genes involved in glutamine synthesis and drug metabolism (Benhamouche et 
al., 2006; Burke et al., 2009; Sekine et al., 2006). Consistent with this role in regulating the 
central fate, activation or attenuation of β-catenin signaling causes expansion or diminution 
of central markers, respectively. Although the role of Wnt/β-catenin signaling is well 
established, the factors determining when and where this pathway is active are still elusive. 
The Rspondin family of Wnt agonists has recently been demonstrated to play a major role in 
determining the levels of Wnt/β-catenin activity (Yoon and Lee, 2012). Upon binding to its 
receptors – the LGRs – Rspondins prevent membrane clearance of Wnt receptors thereby 
promoting Wnt signaling activity (Clevers et al., 2014). This signaling module has recently 
attracted a lot of attention due to its role in stem cell biology, with a particular emphasis on 
LGR5 that has been shown to label stem cells in various tissues, both under physiological 
and pathological conditions (Clevers et al., 2014).  The liver is no exception and Huch et al 
recently demonstrated that LGR5 labels a damage-activated stem cell population (Huch et 
al., 2013). Interestingly, LGR5 was shown to be differentially expressed between periportal 
and pericentral hepatocytes (Braeuning et al., 2006). LGR5 mRNA was exclusively identified 
in pericentral hepatocytes in accordance with the observed Wnt/β-catenin signaling activity 
in adult livers. This observation led us to investigate whether Rspondins play a role in 
determining Wnt/β-catenin signaling activity, and therefore in regulating liver metabolic 
zonation. 
 
Results 
Rspo3 is an endothelial specific marker demonstrating lobular zonation. 
Rspondin expression has previously been analyzed during development, but no liver-specific 
expression has been reported (Nam et al., 2007). Because liver zonation is established soon 
after birth and maintained through adulthood, we began by characterizing their expression 
profile at later stages of liver development, namely at E17.5, at P10 as a representative time 
point for the postnatal period and in adulthood (8 weeks of age). RT-PCR analysis 
demonstrated Rspo1 and Rspo3 to be expressed while Rspo2 and Rspo4 were 
undetectable (Figure S1A). Although Rspo1 was easily detectable by RT-PCR, we failed to 
observe a specific expression pattern by in situ hybridization (data not shown). The lack of 
involvement of Rspo1 was further confirmed in knockout animals that showed overall normal 
liver histology and maintained the expression of zonation markers, such as Glutamine 
Synthetase (GS) (Figure S1B and C). Given these observations we focused our attention on 
Rspo3. 
In situ hybridization for Rspo3 demonstrated an exclusively endothelial-specific expression 
pattern as early as E17.5. Interestingly, the signal seemed to be restricted to the central 
vein, whereas endothelial cells localized at sites of ductal plate differentiation (identified by 
high expression of Keratin 18) were consistently negative for Rspo3 (Figure1A). The central 
vein specific expression profile of Rspo3 was maintained in the perinatal period and 
adulthood. To confirm that Rspo3 expression was indeed endothelial we FACS sorted 
CD31+ cells from adult livers and compared the expression profile between sorted cells and 
whole liver. We observed a dramatic enrichment of Rspo3, as well as the Wnt ligands Wnt2 
and Wnt9b in the endothelial compartment (Figure 1C). Hepatocytes surrounding the Rspo3 
positive veins displayed a strong expression of GS, a bona fide Wnt/β-catenin target in 
hepatocytes (Figure 1B).  
Rspo3 is required for the onset and maintenance of metabolic zonation. 
Metabolic zonation has been suggested to involve position-specific differentiation along the 
lobule that begins after birth and becomes fully established soon thereafter (Torre et al., 
2010). The close association between the Rspo3 expression domain and that of central vein 
hepatocyte identity suggested that Rspo3 might be responsible for the functional patterning 
of pericentral hepatocytes by driving Wnt/ β-catenin signaling. Rspo3 knockout mice die 
around E9.5 due to defects in placenta development (Aoki et al., 2007; Kazanskaya et al., 
2008), thus precluding analysis at later time points. Therefore, to functionally evaluate an 
involvement of this gene in liver zonation, we generated cCAG-CreERT2: Rspo3fl/fl mice that 
permit an inducible, ubiquitous deletion of Rspo3 at any given time point. We administered 
tamoxifen to females at E16.5 days of pregnancy to abolish Rspo3 expression during late 
development and perinatal stages (Figure 2A & B). Livers were analyzed at P10, a time point 
where zonation in wildtype mice is fully established. qPCR analysis confirmed efficient 
Rspo3 deletion (98% reduction; p=0,0002).  Loss of Rspo3 had a profound impact on Wnt/ 
β-catenin signaling, as evidenced by the dramatic reduction of the canonical Wnt/β-catenin 
targets Axin2 (90% reduction, p=0,0006) and LGR5 (98% reduction, p=0,0003) (Figure 2C). 
The expression of endothelial specific Wnt2 and Wnt9b were not affected by Rspo3 deletion 
indicating that the observed phenotype is not due to the absence of the Wnt source, but 
rather Rspo3 itself (Figure 2C). Immunohistochemical analysis revealed a complete loss of 
expression of the pericentral zonation marker GS, demonstrating an absolute requirement 
for Rspo3 in establishing pericentral gene expression (Figure 2D). Similarly, expression of 
Oat and Cyp7a1, two other genes restricted to pericentral hepatocytes (Braeuning et al., 
2006) was dramatically reduced (Figure 2E). Moreover, the periportal genes Cyp2f2 and 
Hsd17 showed a dramatic upregulation, further confirming profound defects in the 
establishment of liver zonation (Figure 2G). E-cadherin, a marker of adult periportal 
hepatocytes, was not yet fully zonated in P10 wildtype livers and - as evidenced in Figure 2F 
- Rspo3 deletion did not result in dramatic changes in its expression pattern. The molecular 
changes were not due to apoptosis of pericentral hepatocytes or to altered liver growth 
(Figure S2A and B). 
Central vein specific expression of Rspo3 is found throughout life. To address whether 
continuous signaling may be required to maintain liver zonation, we induced Rspo3 deletion 
in 8-week old animals (Figure 3A and B). qPCR analysis demonstrated a 50% reduction in 
Rspo3 levels following tamoxifen induction indicating only partial deletion of the floxed allele. 
Importantly, a similar downregulation of the Wnt/β-catenin targets Axin2 and LGR5 was 
observed (Figure 3C). Rspo3 deletion had no impact on Wnt2 and Wnt9b expression (Figure 
3C). GS immunostaining was progressively lost in pericentral hepatocytes and 4 weeks after 
tamoxifen induction, some areas surrounding central veins were completely devoid of GS 
positive cells (Figure 3D). Interestingly endothelial RSPO3 seems to act at a very close 
range, as GS positive cells were observed side by side with negative cells. In situ 
hybridization demonstrated the presence of both recombined and non-recombined cells in 
the same vein (Figure S2E), an observation that might account for the heterogenous GS 
staining pattern. The absence of GS positive cells was not due to apoptosis of pericentral 
hepatocytes, as demonstrated by histological analysis (Figure S2C and D) and the lack of 
activation of caspase 3 (data not shown). qPCR analysis confirmed the decreased 
expression of other zonated genes such as Oat, Cyp7a1 and Rdh9 (Figure 3E). The 
involvement of Rspo3 in maintaining the metabolic functions of the liver was further 
evidenced by a decrease of the amount of direct (conjugated) bilirubin, the conjugation of 
which is performed in pericentral hepatocytes (Figure S2E). 
In adult livers, E-cadherin expression is restricted to periportal hepatocytes. Rspo3 deletion 
induced a progressive expansion of the periportal field, as evidenced by a dramatic increase 
in the number of hepatocyte layers displaying E-cadherin labeling. Expression of other 
periportal genes such as Cyp2f2 and Hsd17 showed an equally dramatic upregulation 
(Figure 3F and G). The observed phenotype mimics the changes previously observed in 
livers from β-catenin KO mutants thus confirming that RSPO3 is required for Wnt/β-catenin 
signaling during adulthood. Thus liver metabolic zonation is driven by an angiocrine factor - 
RSPO3 - that determines Wnt/β-catenin mediated gene expression. 
 
Ectopic expression of Rspo1 is sufficient to induce β-catenin signaling and aberrant 
metabolic zonation 
We next investigated whether Rspondins might be sufficient to imprint a central fate on all 
hepatocytes. Both in vivo and in vitro analyses have demonstrated RSPO1 and RSPO3 to 
be functionally analogous in their activation of canonical β-catenin signaling. Indeed, 
stimulation of the AML12 hepatocyte cell line with recombinant RSPO1 and RSPO3 resulted 
in increased activation of the Wnt/β-catenin signaling pathway albeit with somewhat lower 
efficiency (Figure S3A). We therefore decided to use a Rspo1 gain of function (GOF) allele 
(Rosa26 knock in) previously developed in our group (Figure S3B). 
To ectopically express Rspo1 we used an inducible Alb-CreERT2 system that drives CRE 
recombinase expression specifically within hepatocytes. 8 week old Alb-CreERT2: R26Rspo1/+ 
old animals were treated with tamoxifen and the livers analyzed 2 and 28 days after the last 
injection (Figure 4A and B). Rspo1 induction was accompanied by a dramatic upregulation of 
Axin2 and LGR5, thus validating our hypothesis that RSPO1 is able to induce Wnt/β-catenin, 
when ectopically expressed in hepatocytes (Figure 4C). Following Rspo1 activation a 
transient change in Wnt9b expression was observed that disappeared at later time points 
(Figure 4C). Alb-CreERT2; R26Rspo1/+ double transgenic mice showed a slight increase in 
liver size (Figure S3C), which might be caused by cellular hypertrophy or a slight increase in 
proliferation. This however did not impact on liver structure (Figure S3D). Analysis of GS 
distribution demonstrated an expansion of the pericentral domain, which was progressively 
extended to zone 2 of the liver acinus, demonstrating that RSPO1 is sufficient to activate 
Wnt/β-catenin signaling and therefore induce a progressive expansion of the GS+ 
hepatocytes (Figure 4D and E). Conversely, periportal gene expression was strongly 
downregulated and one month after tamoxifen injection E-cadherin was absent from all 
hepatocytes. qPCR analysis of additional pericentral and periportal genes confirmed that 
zone 2 was functionally converted into zone 1 (Figure 4F and G). These observations were 
further confirmed by the analysis of Alb-CreERT2: R26Rspo1/+ livers induced at E16,5, in 
which we also observed an expansion of the pericentral fate (Figure S4). 
  
Discussion 
β-catenin signaling is a central pathway in liver biology that serves equally important 
functions during development, tissue homeostasis and disease (Monga, 2014). Its role in 
metabolic zonation is well established and both deletion and stabilization (via removal of its 
negative regulator APC) have been shown to have a dramatic impact on lobular gene 
expression (Benhamouche et al., 2006; Burke et al., 2009). ChIP-Seq analysis has 
demonstrated that β-catenin interacts with TCF4 to bind pericentral target genes including 
GS (encoded by Glul), thus demonstrating its direct involvement in transcriptional regulation 
(Torre et al., 2011). A recent study by Yang et al further supported this concept by 
demonstrating that conditional deletion of the Wnt receptors Lrp5/6 in hepatocytes prevented 
the establishment of zonated functions (Yang et al., 2014).  
In the present study we have shown that RSPO3 is specifically expressed in the endothelium 
of the central, but not the portal vein. Restricted expression commences prior to the 
establishment of zonation and deletion of Rspo3 during late stages of development 
interfered with the onset of zonation, thus confirming its essential role in establishing central 
hepatocyte identity. Furthermore, Rspo3 deletion had no impact on Wnt expression levels 
demonstrating that the observed effects are due to Wnt/β-catenin modulation rather than 
loss of Wnt ligands. Surprisingly, some pericentral genes, such as Rdh9, displayed little 
change upon Rspo3 deletion. This suggests that additional mechanisms may contribute to 
regulate hepatic zonation, a hypothesis recently put forward by Gebhardt R and Matz-Soja M 
(Gebhardt and Matz-Soja, 2014). Although dynamics of the zonated genes during the 
perinatal period does not fully recapitulate that of Wnt/β-catenin activity, qPCR analysis of 
the known β-catenin targets Axin2, Oat and Cyp2f2 confirms the strong impact of Rspo3 
deletion or activation of Rspo1 on Wnt/β-catenin driven transcriptional regulation.  
The fact that loss of Rspo/Wnt/β-catenin signaling prevents the activation of the pericentral 
differentiation suggests that portal identity is the hepatocyte default state. Indeed, 
immediately after birth hepatocytes are periportal like and although Wnt/β-catenin signaling 
is fully established by P10, the expression of periportal markers such as E-cadherin (also 
considered as Wnt/β-catenin buffering system) is still retained in most hepatocytes indicating 
that pericentral differentiation is a form of specialization that allows the organism to cope 
with changes in metabolic requirements.  
By adulthood metabolic zonation is firmly established, with precise gene signatures 
distinguishing zone 1 and zone 3 hepatocytes (Braeuning et al., 2006). The expression of 
GS and Cyp7a1 (and Rdh9) closely follows that of the classical Wnt/β-catenin targets Axin2 
and Lgr5 thus further supporting the concept that Wnt/β-catenin is the master regulator of 
liver zonation. While this manuscript was under revision, a paper by Wang et al. reported 
that Wls, a gene essential for the sorting and secretion of WNT proteins, is required within 
the endothelium to drive β-catenin induced cell renewal in central hepatocytes and establish 
zonation (Wang et al., 2015). The observed phenotype in our mutants is similar, but stronger 
than that observed by endothelial deletion Wls demonstrating that Rspo3 plays a crucial role 
in the regulation of Wnt/β-catenin signaling. The authors further identified both Wnt2 and 
Wnt9b to be specifically expressed in endothelial cells of the central vein (Wang et al., 
2015), a finding that nicely confirms our own analysis. While a specific deletion of Wnt2 and 
Wnt9b was not performed in this study, it is likely that these two genes act together with 
Rspo3 to establish and maintain liver zonation. 
Ectopic expression of Rspo1 throughout the liver acinus resulted in the transformation of 
zone 2 hepatocytes to a pericentral (zone 3) identity, as evidenced by the expansion of the 
number of GS+ hepatocyte layers. Surprisingly, hepatocytes close to the periportal system 
failed to express GS. This is in contrast to mice carrying hepatocyte-specific deletion of APC, 
a negative regulator of β-catenin signaling (Benhamouche et al., 2006). APC levels are 
higher in periportal hepatocytes (Benhamouche et al., 2006) and it is conceivable that β-
catenin activation by the Rspo1 GOF allele was insufficient to completely overcome the 
periportal APC activity. Of note, RSPO1 is less efficient in supporting canonical β-catenin 
signaling when compared to RSPO3 in cell culture systems (Kim et al., 2008). Similarly in 
AML12 cells, recombinant RSPO1 required ten times higher concentrations than RSPO3 to 
induce similar levels of Axin2.  
An alternative explanation for the conversion of zone 2 hepatocytes in Rspo1 
overexpressing mice could be the expansion of the recently identified Axin2+ progenitors 
(Wang et al., 2015) that in combination with a permissive signaling environment (high Rspo1 
levels) would keep their identity while being displaced along the central-portal axis. Although 
plausible, this hypothesis has several pitfalls: 1) the expansion of the GS+ domain occurs in 
a reasonably short time frame when compared to the time required for Axin2+ progenitors to 
replace the liver parenchyma (Wang et al., 2015); 2) while periportal hepatocytes fail to 
activate the Wnt/β-catenin target GS, they do respond to Rspo1 upregulation, as evidenced 
by the loss of E-cadherin expression; 3) long term follow up of the GOF animals (9 months) 
fail to demonstrate an expansion of the GS+ hepatocytes towards the portal vein. These 
observations suggest that Rspo1 is inducing Wnt/β-catenin signaling, probably by amplifying 
endogenous low level Wnt signals that are absent from periportal hepatocytes. Alternatively, 
a counteracting signal, potentially released from the periportal triad, could interfere with full-
blown activation of β-catenin signaling in our gain of function model. 
Rspondins are generally considered as facilitators of Wnt/β-catenin signaling that exert their 
function by binding to LGR receptors, most notably LGR5. LGR5 expression appears to be 
very low in the liver and we were unable to detect expression by ISH or antibody staining. 
Similarly, lineage-tracing experiments using an LGR5-CreERT2 line did not mark central 
hepatocytes (Huch et al., 2013). While expression appears to be low, differential microarray 
analysis of central versus portal hepatocytes identified LGR5 to be enriched in central 
hepatocytes, which is consistent with an RSPO3-LGR5-β-catenin cascade in this 
compartment. Wang et al recently performed a lineage tracing analysis of Axin2+ 
hepatocytes and demonstrated that under physiological conditions, pericentral hepatocytes 
function as progenitors that replace the parenchyma after one year. They further reported 
the existence of a progenitor niche provided by endothelial Wnt2 and Wnt9b (Wang et al., 
2015). Interestingly, loss of Wnt ligands resulted in decreased, but not abolished proliferation 
of GS+ hepatocytes. However, the presence of GS in these pericentral hepatocytes 
suggests that residual Wnt/β-catenin signaling persisted in their model, which might account 
for the small differences observed. Rspo3 KO animals completely lack GS expression and it 
would be interesting to test whether progenitor expansion would be more strongly affected in 
these mutants. Unfortunately, ubiquitous deletion of Rspo3 causes mortality 6 weeks 
following induction thus preventing long-term analysis. 
In conclusion our data imply that Rspondin activity is required for Wnt induced signaling, and 
may therefore be considered as a gatekeeper for the activation of the β-catenin pathway in 
liver hepatocytes. The specific expression of Rspo3, Wnt2 and Wnt9b in central veins is 
intriguing, as they allow distinction of the endothelial compartments of the liver on the 
molecular level. Although several hypotheses have been put forward to explain the 
mechanisms responsible for the onset and maintenance of metabolic zonation (Gebhardt 
and Matz-Soja, 2014; Torre et al., 2010), the signal triggering Wnt/β-catenin activation has 
remained elusive. Potential signals may include gradients of oxygen, nutrients, metabolites, 
hormones and cytokines along the lobules (Gebhardt and Matz-Soja, 2014). Whatever the 
mechanism, it seems likely that it will directly influence and induce the expression of Rspo3 
in the endothelial compartment of central veins. The identification of RSPO3 as a key 
regulator of central identity may allow the identification of such signaling pathways, by 
monitoring the expression of RSPO3 under various conditions. 
 
EXPERIMENTAL PROCEDURES 
Mice 
All animal work was conducted according to national and international guidelines. The cCAG 
CreERT2; and Alb CreERT2 mouse lines were previously described (Hayashi and McMahon, 
2002; Schuler et al., 2004). The Rspo3 conditional allele has been generated at the Riken 
core facility and will be described elsewhere (details on request). Rspo3 deletion was 
achieved by intraperitoneal injection (i.p.) of 5 mg of tamoxifen (Sigma-Aldrich) dissolved in 
corn oil (Sigma-Aldrich), per 25 g of body weight. Cre activation in the perinatal period was 
obtained by a single tamoxifen administration into pregnant females carrying E16.5 embryos. 
Cre activation in adult mice was obtained by administrating tamoxifen for every other day for 
one week starting at 8 weeks of age.  
 
Immunofluorescence and Histological Analysis 
For immunofluorescence experiments, tissues were fixed overnight in ANTIGENFIX 
(DiaPath), progressively dehydrated, and paraffin-embedded. 5 µm thick sections were 
rehydrated, boiled in a pressure cooker for 2 min with Antigen Unmasking Solution (Vector 
Laboratories), and blocked in a PBS solution containing 10% normal donkey serum (Jackson 
Immunoresearch) and 1% BSA and 0,1% TritonX100. All primary antibodies were applied 
overnight at 40C at the concentration listed in the Supplemental Experimental Procedures. 
Secondary antibodies were diluted 1:400 and applied at room temperature for 1 hr. 
Glutamine Synthetase immunofluorescence after RNA in situ hybridization was performed 
without antigen retrieval. For histological analysis, tissues were fixed overnight in 
ANTIGENFIX (DiaPath) progressively dehydrated and embedded in paraffin-embedding 
media. 5 µm thick sections were then stained with Hematoxylin and Eosin (HE). 
 
RNA In Situ Hybridization 
Tissues were fixed overnight in ANTIGENFIX (DiaPath), progressively dehydrated, and 
paraffin-embedded. Then 7 µm thick sections were hybridized with Rspo3 probe (details on 
request) according to previously described protocols (Comai et al., 2010).  
 
Cell culture 
The AML12 cell line was maintained in a 1:1 mixture of Dulbecco's modified Eagle's medium 
and Ham's F12 medium with 0.005 mg/ml insulin, 0.005 mg/ml transferrin, 5 ng/ml selenium, 
40ng/ml dexamethasone and 10% fetal bovine serum, in a humidified atmosphere (5% CO2) 
at 37°C. All culture reagents were purchased from Invitrogen (Carlsbad, CA). All stimulations 
were performed according to the following procedure: cells were propagated in standard 
culture medium, serum-starved for 12 h, after which recombinant mouse RSPO1 or RSPO3 
proteins (R&D) were added in fresh serum-free medium. Cells were stimulated for 24h and 
RNA was extracted.  
 
Liver cell isolation and flow cytometry 
Livers were collected from 8 week old animals and non parenchymal cells were isolated 
following the protocol described by Rountree et al (Rountree et al., 2011). Briefly, the tissue 
was digested in PBS containing 5mg collagenase type I (Worthington), 5mg pronase 
(Roche) and 1mg DNase (Roche) for 30 min at 37C. The liver was dissociated and passed 
through a 70 μm filter. Hepatocytes were separated from non parenchymal cells by serial 
low speed centrifugations (50g for 1 min). The supernatant was then stained with CD31-647 
(eBioscience). Cells were analysed with a FACS ARIA II (BD). 
 
RT-qPCR 
RNA was extracted from AML12 cells, P10 or adult livers using TRIzol reagent (Invitrogen), 
following the manufacturer’s instructions. Reverse transcription was performed using M-MLV 
reverse transcriptase (Invitrogen) in combination with polydT primers. The cDNA obtained 
was then used as a template for quantitative PCR carried out using the Syber Green Master 
Kit (Roche) and a Light Cycler 480 (Roche). Expression levels were normalized for GAPDH. 
Primers (see primers list in the Supplemental Experimental Procedures) were designed on 
the Roche Universal Probe Library website. 
 
Statistical Analysis 
Statistical analysis was performed according to the Student’s t test. Error estimates values 
are expressed as SD. 
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Figure legends 
 
 Figure 1: Rspo3 is an endothelial marker displaying liver patterning. 
 (A) Rspo3 in situ hybridization and immuno-labeling of Keratin 18 (green) in E17.5 livers. 
Rspo3-positive endothelial cells were restricted to the central vein, as evidenced by the lack 
of a differentiating ductal plate labeled by Keratin 18 expression (middle panel).  (B) Rspo3 
positive cells (blue) are detected in the central vein endothelium in P10 and 8-week old 
animals. Few Rspo3+ cells can be found in the liver sinusoids in the vicinity of central veins. 
The Rspo3 expression domain overlaps with that of zone 3 hepatocytes as evidenced by 
Glutamine Synthetase labeling (green). See also Supplementary Figure 1. (C) qPCR 
analysis demonstrating Rspo3, Wnt2 and Wnt9b enrichment in CD31+ sorted endothelial 
cells. * p< 0.05; **0.05< p< 0.001, *** p< 0.001 using student T test. All scale bars represent 
50μm; error bars represent SD. 
 
Figure 2: Rspo3 is required for the onset of metabolic zonation. 
(A) Schematic representation of the genetic approach used to delete Rspo3. Red 
arrowheads indicate LoxP sites. (B) Tamoxifen induction protocol used to delete Rspo3 in 
the perinatal period. (C) qPCR analysis demonstrating efficient Rspo3 deletion and an 80-
90% downregulation of the Wnt/β-catenin target genes Axin2 and LGR5. (D) GS expression 
(red) is lost in pericentral hepatocytes following Rspo3 deletion. The endothelial Wnt ligands 
Wnt2 and Wnt9b remained unchanged. Portal tracts can be identified by bile ducts labeled 
by Krt18 (green). (E) qPCR analysis of additional Wnt/β-catenin target/zonated genes 
demonstrated downregulation of pericentral restricted genes. (F) E-cadherin immunostaining 
(green) demonstrating a shift in its expression gradient. (G) Wnt/β-catenin negative targets 
become strongly upregulated by Rspo3 deletion. cv, central vein; pv, portal vein. * p< 0.05; 
**0.05< p< 0.001, *** p< 0.001 using student T test. All scale bars represent 100μm; error 
bars represent SD. See also Supplementary Figure S2 
 
Figure 3: Rspo3 is required for the maintenance of metabolic zonation. 
(A) Schematic representation of the genetic approach used to delete Rspo3 in adulthood. 
Red arrowheads indicate LoxP sites. (B) Tamoxifen induction protocol used to delete Rspo3 
in 8-week old animals. KO livers were analyzed 2 days and 4 weeks after the final injection. 
(C) qPCR analysis demonstrating partial Rspo3 deletion, absence of changes in Wnt2 and 
Wnt9b expression and a downregulation of the Wnt/β-catenin target genes Axin2 and LGR5. 
(D) GS is expressed in a rim of hepatocytes surrounding the central vein (green), which is 
lost in pericentral hepatocytes following Rspo3 deletion. Portal tracts can be identified by bile 
ducts labeled with Krt18 (red). (E) qPCR analysis of additional Wnt/β-catenin target/zonated 
genes demonstrated downregulation of pericentral-specific genes. (F) E-cadherin 
immunostaining (green) demonstrating a shift in its expression gradient. (G) Wnt/β-catenin 
negative targets become strongly upregulated upon Rspo3 deletion. cv, central vein. * p< 
0.05; **0.05< p< 0.001, *** p< 0.001 using student T test. All scale bars represent 100μm; 
error bars represent SD. See also Supplementary Figure S2 
 
Figure 4: Ectopic Rspo1 expression induces Wnt/β-catenin signaling and disrupts liver 
zonation  
(A) Schematic representation of the genetic approach used to ectopically express Rspo1 in 
adulthood. Red arrowheads indicate LoxP sites. (B) Tamoxifen induction protocol used to 
induce Rspo1 expression in 8-week old animals; livers were analyzed 2 days and 4 weeks 
after the final injection. (C) qPCR analysis demonstrating Rspo1 induction and  upregulation 
of the Wnt/β-catenin target genes Axin2 and LGR5. Wnt2 and Wnt9b expression was not 
significantly affected by Rspo1 expression. (D) In non-induced animals, GS expression is 
restricted to the hepatocytes surrounding the central vein  (green), ectopic expression of 
Rspo1 induces an expansion of the GS+ domain. Portal tracts can be identified by bile ducts 
labeled by Krt18 (red). (E) qPCR analysis of additional Wnt/β-catenin target/zonated genes 
demonstrating upregulation of pericentral genes. (F) Lack of E-cadherin immunostaining 
(green) in periportal hepatocytes demonstrating inhibition of periportal specification by 
RSPO1. (G) Wnt/β-catenin negative targets are strongly inhibited by Rspo1 upregulation. cv, 
central vein. * p< 0.05; **0.05< p< 0.001, *** p< 0.001 using student T test. All scale bars 
represent 100μm; error bars represent SD. See also Supplementary Figures S3 & S4. 
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Figure S4 
Figure S1, related to Figure 1: Rspo1, 2 and 4 are not involved in liver 
development and homeostasis (A) Expression profile of Rspondin family members in 
E17.5, P10 and 8 week old livers demonstrating low or absent expression of Rspo2 
and Rspo4 at all stages analysed. cDNAs from whole E10.5 and E12.5 embryos 
were used as positive controls. (B) Haematoxilin and Eosin staining of liver sections 
reveals normal histology in Rspo1 KO mice. (C) Glutamine Synthetase labeling (red) 
is maintained in pericentral hepatocytes demonstrating that Rspo1 deletion has no 
impact on liver zonation. Scale bar represents 50μm (B) and 100μm (C).  
 
Figure S2, related to Figures 2 and 3: Deletion of Rspo3 does not impair liver 
development and maintenance. (A) Haematoxilin and Eosin staining demonstrating 
overall normal liver histology in Rspo3 KO mice. (B) Liver/Body weight ratios at P10 
remain unaltered demonstrating that Rspo3 is not required for liver growth. (C) 
Haematoxilin and Eosin staining in 8 week old animals showing lack of major 
changes in liver histology in Rspo3 KO mice. (D) Liver/Body weight ratios in adult 
mice, showing that deletion of Rspo3 has no dramatic impact on tissue maintenance. 
(E) Billirubin quantification demonstrating defects in glucorinidation process (F) 
Rspo3 in situ hybridization demonstrating heterogeneous gene recombination 2 days 
following tamoxifen induction. GS labeling (green) showing beginning loss (white 
arrowheads) of pericentral identity in zone 3 hepatocytes. cv, central vein; pv, portal 
vein. All scale bars represent 100μm; error bars represent SD.  
 
Figure S3, related to Figure 4: Ectopic Rspo1 expression induces a mild 
hepatomegaly that is not accompanied by changes in liver structure. (A) qPCR 
analysis of the Wnt/β-catenin target genes Axin2 and LGR5 demonstrating that both 
recombinant RSPO1 and RSPO3 are able to induce Wnt/β-catenin signaling (albeit 
at different efficiencies) in the AML12 hepatocyte cell line. (B) Schematic 
representation of the targeting procedure to obtain the conditional Rspo1 gain of 
function allele. The cCAG promoter was inserted in front of a floxed PGK-Neo STOP 
cassette, which prevents expression of Rspo1 before recombination. Cre–induced 
recombination results in excision of the cassette and - as a consequence - activation 
of Rspo1. Green triangle: Lox P site, IVS: intervening sequence, Rspo1 exons are 
represented by grey boxes, black and pink lines indicate Rosa26 Locus and Rspo1 
intron 5-6, respectively, att-B1 and attB2: Gateway cloning sites. (C) Liver/Body 
weight ratios evidencing mild hepatomegaly 2 days following the last tamoxifen 
injection. No further increase in liver size was observed after an additional chase of 4 
weeks. (D) Haematoxilin and Eosin staining demonstrating the absence of gross 
histological abnormalities in Rspo1 GOF livers. cv, central vein; pv, portal vein. * p< 
0.05; **0.05< p< 0.001, *** p< 0.001 using student T test. All scale bars represent 
100μm; error bars represent SD. 
 
 
Figure S4, related to Figure 4: Ectopic Rspo1 expression disrupts the onset of 
metabolic zonation. (A) Schematic representation of the genetic approach used to 
induce Rspo1. Red arrowheads indicate LoxP sites. (B) Tamoxifen induction protocol 
used to induce Rspo1 in the perinatal period (2mg/25 grams of mice). (C) qPCR 
analysis demonstrating an 8 fold increase of Rspo1 expression that is accompanied 
by upregulation of the Wnt/β-catenin target genes Axin2 (4 fold) and Lgr5 (6 fold). (D) 
GS expression (green) is expanded upon Rspo1 induction. Portal tracts can be 
identified by bile ducts labeled by Krt18 (red). (E) qPCR analysis of additional Wnt/β-
catenin target/zonated genes demonstrated upregulation of pericentrally restricted 
genes. (F) E-cadherin immunostaining (green) demonstrating a shift in its expression 
gradient. (G) Wnt/β-catenin negative targets become strongly downregulated upon 
Rspo1 induction. cv, central vein; pv, portal vein. * p< 0.05; **0.05< P< 0.001, *** P< 
0.001 using student T test. All scale bars represent 100μm; error bars represent SD. 
 
 
 
  
Supplementary Tables: 
 
Antibody Table 
 Host Dilution Producer 
Glutamine Synthetase mouse 1:1000 BD Transduction Laboratories 
Keratin 18 rabbit 1:400 Abcam 
E-cadherin  mouse 1:1000 BD Transduction Laboratories 
 
 
 
Primer Table 
Name Forward Reverse Usage 
Axin2  GCAGGAGCCTCACCCTTC TGCCAGTTTCTTTGGCTCTT qPCR 
Cyp2f2 CCGGAACTTTGGAGGCATGAA GGTCATCAGCAGGGTATCCAT qPCR 
Cyp7a1 CACCATTCCTGCAACCTTCT TTGGCCAGCATCTGTAATG qPCR 
Hsd17b13 GATCCTGGAAAAAGGACCTGG GTCTGAAGAGGGTGTCAAATCC qPCR 
LGR5 CTTCACTCGGTGCAGTGCT CAGCCAGCTACCAAATAGGTG qPCR 
Oat CAATTACCATCCTTTGCCTGTA GTACTGCCTGCCTTCCACAT qPCR 
Rdh9 GAGCGTGTTGGGAACAGAG GTTTCTTCATCCACTCGTTGG qPCR 
Rspo1 CGACATGAACAAATGCATCA CCTCCTGACACTTGGTGCAGA RT-PCR; 
qPCR 
Rspo2 CCAACCAGCGAGACAAGAAC GAGGAGGAGCTTGTTTCCTTTC RT-PCR 
Rspo3 CCAACCAGCGAGACAAGAAC GAGGAGGAGCTTGTTTCCTTTC RT-PCR; 
qPCR 
Rspo4 TGTTCTTCTGCCTGGGATTT TCTGAGTCCAGGAAGTGTCCTAT RT-PCR 
    
Alb:CreERT2 GGAACCCAAACTGATGACCA TTAAACAAGCAAAACCAAAT Genotyping 
cCAG:CreERT2 CCCACCGTCAGTACGTGAGATATC CGCGGTCTGGCAGTAAAAACTAT Genotyping 
Rspo3fl/fl CTTCAACTTGAAGGTGCTTTACC CCAGAATGTACAACAGATCCTCTC Genotyping 
Rspo1 GOF CGACCTGCAGCCCAAGCTAG TGTTCATGTCGGGGTTGCGG Genotyping 
 
 
 
 
Supplementary Methods: 
Billirubin levels were quantified using the Billirubin quantification Kit (Sigma-Aldrich) 
according to the manufacturers instructions. Serum was collected from Rspo3 KO 
animals 4 weeks following tamoxifen induction.  
 
